Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.

Renowned business leader and digital transformation expert Brian Lambert, PhD, announces the release of his groundbreaking book, The AI Lead: Overcoming Data Drag to Accelerate Digital Dominance. This ...

The global Cell Therapy Technologies market, valued at US$3.89 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$4.03 ...

Smooth E Invests 200 Million Baht in Major Brand Revamp under "Mild...Effective, Visible Results" Positioning Reinforcing Its ...

One year after the EU mandated separate collection of bio-waste, a significant portion of Europe's organic waste still ends up in landfills and incinerators.

Defiant is a new early stage VC firm focused on B2B SaaS and fintech coming out of stealth today. Joseph Pizzolato (pictured ...

Financing was co-led by Forbion and General Atlantic, with participants including RA Capital Management, OrbiMed, and Lilly Asia Ventures.

Peoria, IL, Jan 8, 2025 — Veloxity Labs, a bioanalytical contract research organization (CRO) specializing in accelerating ...

Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and cardiometabolic disease.

Achieve Business Success in an Unpredictable World by Roger Spitz Disrupt with Impact Shortlisted for Prestigious H ...

Since March of 2021, rap’s most delayed and anticipated album has been subject to name-changes, empty promises, and surprise singles. Here is a four-year timeline of Instagram posts, leaks, snippets, ...